| Literature DB >> 25712359 |
Andrea Trochine1, Darren J Creek2, Paula Faral-Tello3, Michael P Barrett2, Carlos Robello4.
Abstract
Proteases and peptidases in Trypanosoma cruzi are considered potential targets for antichagasic chemotherapy. We monitored changes in low-mass metabolites in T. cruzi epimastigotes treated with bestatin, a dipeptide metalloaminopeptidase inhibitor. After treatment, multiple dipeptides were shown to be increased, confirming in situ inhibition of the leucine aminopeptidase of T. cruzi (LAPTc) and probably other peptidases.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25712359 PMCID: PMC4394807 DOI: 10.1128/AAC.05046-14
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191